Fluticasone Propionate
Product Images NDC 53002-1401

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Fluticasone Propionate (NDC 53002-1401). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fluticasone Propionate Chemical Structure (Fluticasonepropionatehfa Spl Graphic 01)

Chemical structure of Fluticasone Propionate, showing the molecular arrangement and bonding of its atoms as depicted in the image.*

FDA Label Image

Figure 1. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Inadequately Controlled On Bronchodilators Alone: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 1) (Fluticasonepropionatehfa Spl Graphic 02)

A line graph depicting the percent change from baseline in FEV1 over a 12-week period, comparing Fluticasone Propionate HFA 88 mcg twice daily with placebo. The x-axis shows weeks, including an endpoint measurement, and the y-axis shows percent change in FEV1. The Fluticasone Propionate HFA group shows a higher increase in FEV1 across the study period than the placebo group.*

FDA Label Image

Figure 2. A 12-week Clinical Trial In Subjects Aged 12 Years And Older Already Receiving Daily Inhaled Corticosteroids: Mean Percent Change From Baseline In Fev1 Prior To Am Dose (trial 2) (Fluticasonepropionatehfa Spl Graphic 03)

A line graph showing the percent change from baseline in FEV1 over a 12-week period for Placebo and three dosage levels of Fluticasone Propionate HFA (88 mcg, 220 mcg, and 440 mcg twice daily). The graph depicts lung function improvement trends, with Fluticasone dosed groups generally showing greater positive changes compared to Placebo.*

FDA Label Image

Figure 3. A 16-week Clinical Trial In Subjects Aged 12 Years And Older Requiring Chronic Oral Prednisone Therapy: Change In Maintenance Prednisone Dose (Fluticasonepropionatehfa Spl Graphic 04)

Bar chart comparing the percentage of subjects with 100% reduction in dose and those with an increase in dose for placebo and two doses of Fluticasone Propionate HFA (440 mcg twice daily and 880 mcg twice daily). The chart shows higher reductions in dose percentages for both Fluticasone Propionate HFA groups compared to placebo, and lower percentages of subjects with increased dose in Fluticasone groups.*

FDA Label Image

Figure A (Fluticasonepropionatehfa Spl Graphic 05)

An illustration depicting the components of a Fluticasone Propionate HFA inhaler: a metal canister, dark orange plastic actuator, dark orange mouthpiece, a counter on the inhaler body, and a separate peach-colored protective cap.*

FDA Label Image

Figure B (Fluticasonepropionatehfa Spl Graphic 06)

Illustration showing the removal of a small protective cap or cover from the mouthpiece of an inhaler device, held by two hands. An arrow indicates the direction to pull the cap away from the inhaler.*

FDA Label Image

Figure C (Fluticasonepropionatehfa Spl Graphic 07)

Illustration showing how to use a metered-dose inhaler spray. It depicts a person holding the inhaler, pressing down on the canister to release a spray while exhaling or preparing to inhale. The diagram includes an arrow indicating the spray direction and a separate image of the inhaler mouthpiece cap.*

FDA Label Image

Figure D (Fluticasonepropionatehfa Spl Graphic 08)

An instructional illustration showing a hand holding a Fluticasone Propionate HFA inhaler, with the thumb pressing down on the top of the inhaler device. The device has a mouthpiece cover and a visible dose counter displaying the number 120.*

FDA Label Image

Figure E (Fluticasonepropionatehfa Spl Graphic 09)

Instructional diagram showing how to hold the Fluticasone Propionate HFA inhaler in a mouthpiece-down position. The image highlights the dark orange mouthpiece attached to the inhaler and a separate peach cap shown below the device, illustrating their colors and placement.*

FDA Label Image

Figure F (Fluticasonepropionatehfa Spl Graphic 10)

An instructional illustration showing a side profile of a person's face breathing out with the text "Breathe out as much air as you can." This image appears to demonstrate part of the proper technique for using an inhaler device.*

FDA Label Image

Figure G (Fluticasonepropionatehfa Spl Graphic 11)

Instructional illustration showing a person using an inhaler. The image depicts the proper technique to use the inhaler by pushing down on the canister while breathing in. The person holds the inhaler near their mouth, with an arrow indicating the inhalation direction.*

FDA Label Image

Figure H (Fluticasonepropionatehfa Spl Graphic 12)

An instructional illustration depicting a person rinsing their mouth over a sink with water from a glass placed nearby. The image emphasizes oral rinsing and spitting, commonly associated with instructions for inhaled medications such as Fluticasone Propionate HFA.*

FDA Label Image

Figure I (Fluticasonepropionatehfa Spl Graphic 13)

An instructional diagram showing proper and improper use of a Fluticasone Propionate HFA inhaler. The top section labeled 'Not blocked' illustrates correct inhaler use with unobstructed spray. The bottom section labeled 'Blocked' shows incorrect use with the inhaler spray being obstructed.*

FDA Label Image

Figure J (Fluticasonepropionatehfa Spl Graphic 14)

An instructional illustration showing how to clean the spray nozzle of an inhaler device. The image depicts a person using a cotton swab to carefully clean the small spray opening on the inhaler mouthpiece.*

FDA Label Image

Label Image (Lbl530021401)

Fluticasone Propionate HFA 220 MCG inhalation aerosol label from RPK Pharmaceuticals, Inc. The label states the product is generic for Flovent 220 MCG and provides dosing instructions to inhale 2 puffs twice daily or as directed. The package appears to be for a 12-gram bottle with barcodes and spaces for patient and prescriber information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.